Cases & Deals

Life sciences company resolves FCPA issues with DOJ and SEC

Clients Publicly traded life sciences company

Jones Day represented a publicly traded life sciences company in an internal investigation and resulting self-disclosure to the U.S. Department of Justice ("DOJ") and U.S. Securities and Exchange Commission ("SEC") involving alleged Foreign Corrupt Practices Act ("FCPA") violations arising out of the company's China operations. Jones Day assisted the company in negotiating a civil, administrative settlement with the SEC and obtaining a declination from the DOJ.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.